Be The Investor ResearchUnitedHealth's Medical Costs Improved, but Reserve Benefits Matter
UnitedHealth's third-quarter medical-care ratio improved to 88.4% and guidance rose to at least $20.50 per adjusted share. A $610 million reserve benefit helped the result, so underlying utilization remains the key test.
UnitedHealth Group reported an 88.4% medical-care ratio in the third quarter of 2026, down from 89.9% a year earlier. The ratio measures the share of insurance premium revenue spent on medical care, so the decline points to better pricing and cost alignment.
The company also raised full-year adjusted earnings guidance to at least $20.50 per share. Third-quarter adjusted earnings were $4.69 per share, while operating expenses improved as a percentage of revenue.
The quality of the medical-cost improvement needs one important adjustment. UnitedHealth said the quarter included $610 million of favorable prior-period reserve development related to 2026 dates of service.
Reserve development occurs when updated claims information shows that previously recorded medical costs were higher than ultimately needed. It is a legitimate accounting update, but investors should separate it from changes in current utilization and pricing.
Even with the improvement, an 88.4% ratio leaves less than 12 cents of each premium dollar before administrative costs and other expenses. Small changes in hospital use, specialty drugs or Medicare reimbursement can therefore move earnings materially across a very large revenue base.
UnitedHealth has been reducing or repricing membership where economics are unattractive, which can improve margins while limiting revenue growth. The company must balance affordability, benefit design and provider relationships without losing customers to competitors.
The operating-cost ratio improved to 12.8% from 13.5%, providing another source of earnings support. Yet cost reduction cannot substitute for accurate medical pricing if utilization accelerates.
The most useful next disclosures are the medical-care ratio excluding reserve development, utilization trends by business, Medicare Advantage pricing and cash flow from operations. Those measures will show whether the third-quarter improvement is durable.
UnitedHealth's raised guidance and lower care ratio are constructive, but the reserve benefit means the headline should not be read in isolation. The recovery becomes more convincing if current-period claims continue to track pricing without repeated reliance on favorable prior estimates.